In the heart of Geneva, at the 78th World Health Assembly, a quiet storm is brewing. It’s not the kind of tempest that rattles windows or soaks streets—it’s the more insidious kind, one that reshapes international norms while most of the world remains focused on everyday concerns. The World Health Organisation’s proposed Pandemic Agreement has re-entered the spotlight, prompting both applause and alarm in equal measure.
On the surface, the agreement is a noble vision: a coordinated global response to future pandemics, forged in the shadow of the COVID-19 crisis. Who could argue with readiness, with equity, with learning from the mistakes of the past?
But here’s where things get complex.
A Treaty Without Teeth—Yet
At first glance, this isn’t a binding treaty—at least not yet. Adoption this month doesn’t mean immediate enforcement. Countries have 18 months to notify WHO of their intention to accept the agreement. Even then, nothing takes effect until 60 nations ratify it, and a still-unwritten annex on the controversial Pathogen Access and Benefit-Sharing (PABS) System is agreed upon.
It’s a bit like signing a contract with several blank pages—and promising not to criticise it while the rest is filled in.
Consensus or Convenience?
In a notable shift, WHO now suggests that a “consensus” rather than a two-thirds majority vote might suffice to pass the agreement. This has raised eyebrows. Why sidestep a formal vote? Is it pragmatism—or power play?
As the saying goes, “He who controls the process controls the outcome.” And consensus, by its very nature, can be shaped behind closed doors, quietly, efficiently.
The PABS Puzzle
Central to the hold-up is the PABS System, an initiative meant to ensure that all countries—especially low and middle-income ones—share in the benefits of pathogen research. During the COVID-19 pandemic, the world saw firsthand how inequitable vaccine distribution could be. The PABS annex aims to prevent a repeat.
But therein lies the rub. Definitions, legal implications, terms of use—none of it is settled. Countries are being asked to support a framework where one of its most critical components remains a question mark.
What’s Really at Stake?
Critics argue that the agreement’s current language, especially the idea that signatories should not “undermine” the pact, could set a dangerous precedent. What does undermining mean in practice? Could it stifle national debate? Public dissent? Media scrutiny?
In the UK, the Public Health (Control of Disease) Act gives sweeping powers to the Secretary of State—powers that could, theoretically, allow implementation of the agreement without parliamentary approval. That has stirred fears of executive overreach and democratic erosion.
The concern isn’t about pandemics per se—it’s about how the machinery of pandemic response might be used or misused.
A Question of Trust
Perhaps the most provocative question here is one of trust. Should global institutions be given the authority to act swiftly in the face of a future health crisis? Or does such authority risk becoming a Trojan horse for expanded control and suppressed dissent?
In this moment, we must remember: governance is only as sound as the consent it commands. And consent without clarity is little more than coercion in a friendly mask.
The Long Road Ahead
Even the most ardent supporters of the agreement admit: this is a long game. Years may pass before the treaty is fully ratified, before its terms are enforceable. But what we do now—what we question, what we accept, what we overlook—sets the trajectory.
We are, as ever, caught between urgency and uncertainty. The desire to protect public health must be weighed against the need to preserve civic freedoms. It’s a delicate balance—one that demands not blind allegiance, but vigilant engagement.
So, the next time you hear talk of pandemic preparedness, ask not just “how,” but also “who decides?” And more importantly—on whose behalf?
Original Article: The Exposé
